JP2024500932A5 - - Google Patents
Info
- Publication number
- JP2024500932A5 JP2024500932A5 JP2023538702A JP2023538702A JP2024500932A5 JP 2024500932 A5 JP2024500932 A5 JP 2024500932A5 JP 2023538702 A JP2023538702 A JP 2023538702A JP 2023538702 A JP2023538702 A JP 2023538702A JP 2024500932 A5 JP2024500932 A5 JP 2024500932A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LULU102326 | 2020-12-22 | ||
| LU102326 | 2020-12-22 | ||
| PCT/EP2021/086992 WO2022136370A1 (en) | 2020-12-22 | 2021-12-21 | Application of crispr/cas13 for therapy of rna virus and/or bacterium induced diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024500932A JP2024500932A (ja) | 2024-01-10 |
| JPWO2022136370A5 JPWO2022136370A5 (https=) | 2025-01-31 |
| JP2024500932A5 true JP2024500932A5 (https=) | 2025-01-31 |
Family
ID=74626052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538702A Pending JP2024500932A (ja) | 2020-12-22 | 2021-12-21 | Ｒｎａウイルスおよび／または細菌誘発性の疾患の治療に対するｃｒｉｓｐｒ／ｃａｓ１３の応用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240041990A1 (https=) |
| EP (1) | EP4267736A1 (https=) |
| JP (1) | JP2024500932A (https=) |
| CN (1) | CN116917478A (https=) |
| CA (1) | CA3203046A1 (https=) |
| WO (1) | WO2022136370A1 (https=) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| EP1025217B1 (en) | 1997-10-24 | 2006-10-04 | Invitrogen Corporation | Recombinational cloning using nucleic acids having recombination sites |
| US10056224B2 (en) | 2015-08-10 | 2018-08-21 | Kla-Tencor Corporation | Method and system for edge-of-wafer inspection and review |
| CA3028158A1 (en) * | 2016-06-17 | 2017-12-21 | The Broad Institute, Inc. | Type vi crispr orthologs and systems |
| CN111108220B (zh) * | 2017-03-15 | 2024-11-19 | 博德研究所 | 用于病毒检测的基于crispr效应系统的诊断 |
| AU2018234825B2 (en) * | 2017-03-15 | 2020-12-17 | Massachusetts Institute Of Technology | Novel CAS13B orthologues CRISPR enzymes and systems |
| US11168322B2 (en) * | 2017-06-30 | 2021-11-09 | Arbor Biotechnologies, Inc. | CRISPR RNA targeting enzymes and systems and uses thereof |
| WO2019010422A1 (en) * | 2017-07-07 | 2019-01-10 | The Broad Institute, Inc. | ANTIVIRAL THERAPY BASED ON THE CRISPR SYSTEM |
| WO2019018423A1 (en) * | 2017-07-17 | 2019-01-24 | The Broad Institute, Inc. | NEW TYPE VI CRISPR ORTHOLOGISTS AND ASSOCIATED SYSTEMS |
| US10476825B2 (en) * | 2017-08-22 | 2019-11-12 | Salk Institue for Biological Studies | RNA targeting methods and compositions |
| CN107939288B (zh) | 2017-11-14 | 2019-04-02 | 中国科学院地质与地球物理研究所 | 一种非旋转套的防转装置以及旋转导向装置 |
| CN113348245A (zh) * | 2018-07-31 | 2021-09-03 | 博德研究所 | 新型crispr酶和系统 |
| US12258594B2 (en) * | 2018-12-05 | 2025-03-25 | The Broad Institute, Inc. | Cas proteins with reduced immunogenicity and methods of screening thereof |
| CN110656123B (zh) * | 2019-10-12 | 2021-07-13 | 中国农业大学 | 基于CRISPR-Cas13d系统的sgRNA高效作用靶点的筛选方法及应用 |
-
2021
- 2021-12-21 WO PCT/EP2021/086992 patent/WO2022136370A1/en not_active Ceased
- 2021-12-21 JP JP2023538702A patent/JP2024500932A/ja active Pending
- 2021-12-21 CN CN202180094344.1A patent/CN116917478A/zh active Pending
- 2021-12-21 EP EP21843704.4A patent/EP4267736A1/en active Pending
- 2021-12-21 CA CA3203046A patent/CA3203046A1/en active Pending
- 2021-12-21 US US18/268,948 patent/US20240041990A1/en active Pending